Cargando…
Randomized controlled trials of remdesivir in hospitalized coronavirus disease 2019 patients: A meta-analysis
BACKGROUND: The first cases of the coronavirus disease 2019 (COVID-19) were reported in Wuhan, China. No antiviral treatment options are currently available with proven clinical efficacy. However, preliminary findings from phase III trials suggest that remdesivir is an effective and safe treatment o...
Autores principales: | Sarfraz, Azza, Sarfraz, Zouina, Sanchez-Gonzalez, Marcos, Michel, Jack, Michel, George, Frontela, Odalys, Posada, Jorge, Cardona, Jose, Angueira, Eugenio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091999/ https://www.ncbi.nlm.nih.gov/pubmed/33969238 http://dx.doi.org/10.4103/2452-2473.309139 |
Ejemplares similares
-
Cardiovascular Disease, Intensive Care, and Mortality in Coronavirus Disease 2019 Patients: A Meta-Analysis
por: Sarfraz, Zouina, et al.
Publicado: (2022) -
Ripple Collision of Three Epidemics: Vaping, Opioid Use, and COVID-19
por: Sarfraz, Zouina, et al.
Publicado: (2021) -
Tocilizumab and COVID-19: a meta-analysis of 2120 patients with severe disease and implications for clinical trial methodologies
por: SARFRAZ, Azza, et al.
Publicado: (2021) -
Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis
por: Sarfraz, Azza, et al.
Publicado: (2021) -
Editorial: A Changing Epidemic and the Rise of Opioid-Stimulant Co-Use
por: Ahmed, Saeed, et al.
Publicado: (2022)